# ENDRA Life Sciences Inc.: Form 8-K, filed Mar 29, 2018

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2018-03-29
- Accepted by EDGAR: Mar 29, 2018, 16:21 ET
- Period: 2018-03-29
- Accession: 0001654954-18-003377
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495418003377/ndra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495418003377/

## Items reported

- Item 5.08: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495418003377/ndra_8k.htm

Filed Mar 29, 2018.
Source: SEC EDGAR, the filing index for accession 0001654954-18-003377. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
